Federal court sides with DEA’s denial of access to psilocybin for terminally ill patients; COMPASS trigger law in Kansas; Could Arizona be first on ibogaine?
Plus: UK considerations for psychedelic-assisted therapy, and reviewing heart risks of psychedelics
1 person likes this.
Psychedelic ibogaine can now be produced without rare plants
Scientists created ibogaine synthetically, avoiding plant sourcing. This breakthrough supports addiction research and safer treatments.
Be the first person to like this.
The risks of mixing ayahuasca and SSRIs: 5 Questions for UCLA psychiatry professor Charles Grob
Grob discusses ayahuasca's risks, his research on the substance, and the growing need for new ayahuasca studies.
Be the first person to like this.
Willy Myco Just Released the First-Ever Video Demonstrating How to Synthesize LSD
Willy Myco recently lectured on psychedelics at Pakistan’s University of Okara in exchange for filming a researcher there synthesize LSD.
4 people like this.
I think it's helpful to have the pdf and the video. T rex ophora says Uncle Fester gives more info regarding different precursors
Well, I'm definitely not gonna be getting rid of it hahaha, I have a small library of drug information books on my computer, just hoarding all the information that I can.
Honestly I've been thinking about printing all of them off and putting them in 3-ring binders.
DUDE i was thinking of doing the same thing! Lol i have already printed some actually just havent put holes and gotten them in a binder.
Psychedelics Don’t Heal Addiction—They Return us to Wholeness
Welcome to The Psychedelic Blog. I write about the Impact of Psychedelics on Grieving, Relationships, Culture, and Death.
Be the first person to like this.
Be the first person to like this.
Be the first person to like this.
Mindstate Uses AI to Design "Next-Gen" Psychedelics Combined With 5-MeO-MiPT - Lucid News
Mindstate Design Labs has received approval for a Phase 1 clinical trial to investigate the use of its formulation of 5-MeO-MiPT which it hopes to combine with other drugs to target precise serotonin
Be the first person to like this.
Another Psychedelic Drug Derivative Secures Patent and Awaits FDA Approval
EB-002 is touted as a “next-generation” psilocin pro-drug and will be used as a stepping stone for future, trip-free psychedelic meds.
2 people like this.
